MSK experts believe that giving the targeted drug asciminib to patients with chronic myeloid leukemia at the beginning of ...

Rakesh Jain PhD, Director of the E.L. Steele Laboratories for Tumor Biology at Massachusetts General Hospital and A. Werk ...

MB-105, a first-in-class CD5-targeted CAR T-cell therapy, received FDA orphan drug designation for relapsed/refractory T-cell ...

New research published today in Nature identifies a pathway that keeps the cancer cells alive long enough to evolve such resistance, and shows that inhibiting this pathway in mice with acute ...

KU School of Medicine-Wichita Department of Pediatrics and Wesley Children’s Hospital say a groundbreaking treatment for ...

The FDA has approved GRAFAPEX™ and fludarabine as a preparative regimen in acute myeloid leukemia or myelodysplastic syndrome ...

The China-based drug developer’s offering will fund testing of medicines for several blood malignancies — one of which is ...

Researchers designed oligopeptides that could co-assemble with therapeutic cargoes to create nanoparticles that improved the ...

Scientists have developed a groundbreaking approach using specially designed peptides to improve drug formulations. This innovative method significantly enhances anti-tumor efficacy.

Targeted therapies for high-risk leukemia in children have yet to be developed, but scientists at Université de Montréal and ...